Multiple Kronecker RLS fusion-based link propagation for drug-side effect prediction
- URL: http://arxiv.org/abs/2407.00105v1
- Date: Thu, 27 Jun 2024 08:50:25 GMT
- Title: Multiple Kronecker RLS fusion-based link propagation for drug-side effect prediction
- Authors: Yuqing Qian, Ziyu Zheng, Prayag Tiwari, Yijie Ding, Quan Zou,
- Abstract summary: Drug-side effect prediction is a link prediction problem, and the related data can be described from various perspectives.
To process these kinds of data, a multi-view method, called Multiple Kronecker RLS fusion-based link propagation (MKronRLSF-LP), is proposed.
- Score: 7.168105118038268
- License: http://creativecommons.org/licenses/by/4.0/
- Abstract: Drug-side effect prediction has become an essential area of research in the field of pharmacology. As the use of medications continues to rise, so does the importance of understanding and mitigating the potential risks associated with them. At present, researchers have turned to data-driven methods to predict drug-side effects. Drug-side effect prediction is a link prediction problem, and the related data can be described from various perspectives. To process these kinds of data, a multi-view method, called Multiple Kronecker RLS fusion-based link propagation (MKronRLSF-LP), is proposed. MKronRLSF-LP extends the Kron-RLS by finding the consensus partitions and multiple graph Laplacian constraints in the multi-view setting. Both of these multi-view settings contribute to a higher quality result. Extensive experiments have been conducted on drug-side effect datasets, and our empirical results provide evidence that our approach is effective and robust.
Related papers
- XAI for In-hospital Mortality Prediction via Multimodal ICU Data [57.73357047856416]
We propose an efficient, explainable AI solution for predicting in-hospital mortality via multimodal ICU data.
We employ multimodal learning in our framework, which can receive heterogeneous inputs from clinical data and make decisions.
Our framework can be easily transferred to other clinical tasks, which facilitates the discovery of crucial factors in healthcare research.
arXiv Detail & Related papers (2023-12-29T14:28:04Z) - Multiscale Topology in Interactomic Network: From Transcriptome to
Antiaddiction Drug Repurposing [0.3683202928838613]
The escalating drug addiction crisis in the United States underscores the urgent need for innovative therapeutic strategies.
This study embarked on an innovative and rigorous strategy to unearth potential drug repurposing candidates for opioid and cocaine addiction treatment.
arXiv Detail & Related papers (2023-12-03T04:01:38Z) - The Blessings of Multiple Treatments and Outcomes in Treatment Effect
Estimation [53.81860494566915]
Existing studies leveraged proxy variables or multiple treatments to adjust for confounding bias.
In many real-world scenarios, there is greater interest in studying the effects on multiple outcomes.
We show that parallel studies of multiple outcomes involved in this setting can assist each other in causal identification.
arXiv Detail & Related papers (2023-09-29T14:33:48Z) - Drug Synergistic Combinations Predictions via Large-Scale Pre-Training
and Graph Structure Learning [82.93806087715507]
Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation.
Deep learning models have emerged as an efficient way to discover synergistic combinations.
Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
arXiv Detail & Related papers (2023-01-14T15:07:43Z) - Unsupervised EHR-based Phenotyping via Matrix and Tensor Decompositions [0.6875312133832078]
We provide a comprehensive review of low-rank approximation-based approaches for computational phenotyping.
Recent developments have adapted low-rank data approximation methods by incorporating different constraints and regularizations that facilitate interpretability further.
arXiv Detail & Related papers (2022-09-01T09:47:27Z) - SSM-DTA: Breaking the Barriers of Data Scarcity in Drug-Target Affinity
Prediction [127.43571146741984]
Drug-Target Affinity (DTA) is of vital importance in early-stage drug discovery.
wet experiments remain the most reliable method, but they are time-consuming and resource-intensive.
Existing methods have primarily focused on developing techniques based on the available DTA data, without adequately addressing the data scarcity issue.
We present the SSM-DTA framework, which incorporates three simple yet highly effective strategies.
arXiv Detail & Related papers (2022-06-20T14:53:25Z) - Modular multi-source prediction of drug side-effects with DruGNN [3.229607826010618]
Drug Side-Effects (DSEs) have a high impact on public health, care system costs, and drug discovery processes.
To predict their occurrence, it is necessary to integrate data from heterogeneous sources.
In this work, such heterogeneous data is integrated into a graph dataset, expressively representing the relational information between different entities.
Graph Neural Networks (GNNs) are exploited to predict DSEs on our dataset with very promising results.
arXiv Detail & Related papers (2022-02-15T09:41:05Z) - Multiple Similarity Drug-Target Interaction Prediction with Random Walks
and Matrix Factorization [16.41618129467975]
We take a multi-layered network perspective, where different layers correspond to different similarity metrics between drugs and targets.
To fully take advantage of topology information captured in multiple views, we develop an optimization framework, called MDMF, for DTI prediction.
The framework learns vector representations of drugs and targets that not only retain higher-order proximity across all hyper-layers, but also approximates the interactions with their inner product.
arXiv Detail & Related papers (2022-01-24T08:02:05Z) - SurvITE: Learning Heterogeneous Treatment Effects from Time-to-Event
Data [83.50281440043241]
We study the problem of inferring heterogeneous treatment effects from time-to-event data.
We propose a novel deep learning method for treatment-specific hazard estimation based on balancing representations.
arXiv Detail & Related papers (2021-10-26T20:13:17Z) - Enabling Counterfactual Survival Analysis with Balanced Representations [64.17342727357618]
Survival data are frequently encountered across diverse medical applications, i.e., drug development, risk profiling, and clinical trials.
We propose a theoretically grounded unified framework for counterfactual inference applicable to survival outcomes.
arXiv Detail & Related papers (2020-06-14T01:15:00Z) - Reinforcement learning and Bayesian data assimilation for model-informed
precision dosing in oncology [0.0]
Current strategies comprise model-informed dosing tables or are based on maximum a-posteriori estimates.
We propose three novel approaches for MIPD employing Bayesian data assimilation and/or reinforcement learning to control neutropenia.
These approaches have the potential to substantially reduce the incidence of life-threatening grade 4 and subtherapeutic grade 0 neutropenia.
arXiv Detail & Related papers (2020-06-01T16:38:27Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.